Table 1

The variants in PLXNB2 identified in six families and the disease features observed

Patient (sex/age range)Zygosity and variants (NM_012401.4, NP_036533.2)Phenotype
AuditoryDentalDevelopmental/neurologicalVisionOther
Family 1 II:3
(M/12–18)
Homozygous c.2413A>T: p.(Ile805Phe); c.2413A>T: p.(Ile805Phe)SNHLAI, conical permanent incisorsGlobal developmental delay, moderate intellectual disabilityMyopia, horizontal nystagmus (congenital cataract due to CRYBB3 variant)Ear lobe skin blind-ended tracts
Family 1 II:6
(M/19–21)
Homozygous c.2413A>T: p.(Ile805Phe); c.2413A>T: p.(Ile805Phe)SNHL; labyrinthine malformationAI, conical permanent incisorsGlobal developmental delay, epilepsy, moderate intellectual disabilitySevere myopia with scattered papillae, horizontal nystagmus, macular atrophyEar lobe skin blind-ended tracts, unilateral renal agenesis, pyloric stenosis, asthma, recurrent bronchitis, intrauterine growth retardation, finger pads, watch glass toenails, overweight
Family 2 IV:2 (M/12–18)Homozygous c.2248G>A: p.(Asp750Asn); c.2248G>A: p.(Asp750Asn)SNHLAIIntellectual disabilityNo obvious abnormality, not examined
Family 3 II:1
(M/6–11)
Compound heterozygous c.750C>A: p.(Cys250*); c.3117G>A: p.(Thr1039=)SNHL (mild) 500–4000 HzAI with hypoplasiaNormalDevelopmental macular abnormality with pale fundus, attenuated blood vessels, high myopia, nystagmus, microcorneaEar lobe skin blind-ended tracts, cleft palate, hypertelorism, keratopathy
Family 4 II:1
(F/19–21)
Compound heterozygous c.2606del: p.(Phe869Serfs*45); c.3982_3986del: p.(Phe1328His*65)SNHLAI; missing upper permanent lateral incisorsNormalNo obvious abnormality, not examinedEar lobe skin blind-ended tracts, bilateral primary lower limb lymphoedema (onset aged 3),
nevus, cellulitis
Family 5
II:1
(F/50–59)
Homozygous c.5197-337_5310del: p.(Asp1733_Arg1779del); c.5197-337_5310del: p.(Asp1733_Arg1779del)SNHLAIMild/moderate intellectual disabilityNo obvious abnormality, not examinedBilateral primary lower limb lymphoedema
Family 5
II:2
(M/50–59)
Homozygous c.5197-337_5310del: p.(Asp1733_Met1770del); c.5197-337_5310del: p.(Asp1733_Met1770del)SNHLAIIntellectual disabilityNo obvious abnormality, not examinedUnilateral lymphoedema of one foot
Family 6
III:1
(M/2–5)
Homozygous c.4609G>A: p.(Gly1537Ser); c.4609G>A: p.(Gly1537Ser)Could not be assessed; no current indication of hearing lossClinical tooth failure (cause unclear); could not be assessed furtherProfound intellectual disability, non-verbal, autistic features, hyperactive behaviourStrabismus, no other obvious abnormality, could not be assessedMild generalised muscular hypotonia
  • Splicing prediction tools suggest that exon 35 is entirely skipped leading to p.(Asp1733_Arg1779del) instead of p.(Asp1733_Met1770del) as would be predicted from the proportion of the gene deleted. Age ranges are shown for individuals to maintain anonymity. Age of onset was from birth unless otherwise stated. Variants are based on genome build GRCh37 and PLXNB2 transcript ENST00000359337.9, NM_012401.4 and PLXNB2 protein ENSP00000352288.4, NP_036533.2.

  • AI, amelogenesis imperfecta; SNHL, sensorineural hearing loss.